Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA

J Antimicrob Chemother. 2014 Feb;69(2):404-15. doi: 10.1093/jac/dkt348. Epub 2013 Sep 10.

Abstract

Objectives: A region in the conserved 5' long terminal repeat (LTR) promoter of the integrated HIV-1C provirus was identified for effective targeting by a short double-stranded RNA (dsRNA) to cause heterochromatization leading to a long-lasting decrease in viral transcription, replication and subsequent productive infection in human host cells.

Methods: Small interfering RNAs (siRNAs) were transfected into siHa cells containing integrated LTR-luciferase reporter constructs and screened for efficiency of inducing transcriptional gene silencing (TGS). TGS was assessed by a dual luciferase assay and real-time PCR. Chromatin modification at the targeted region was also studied. The efficacy of potent siRNA was then checked for effectiveness in TZM-bl cells and human peripheral blood mononuclear cells (PBMCs) infected with HIV-1C virus. Viral Gag-p24 antigen levels were determined by ELISA.

Results: One HIV-1C LTR-specific siRNA significantly decreased luciferase activity and its mRNA expression with no such effect on HIV-1B LTR. This siRNA-mediated TGS was induced by histone methylation, which leads to heterochromatization of the targeted LTR region. The same siRNA also substantially suppressed viral replication in TZM-bl cells and human PBMCs infected with various HIV-1C clinical isolates for ≥3 weeks after a single transfection, even of a strain that had a mismatch in the target region.

Conclusions: We have identified a potent dsRNA that causes long-term suppression of HIV-1C virus production in vitro and ex vivo by heritable epigenetic modification at the targeted C-LTR region. This dsRNA has promising therapeutic potential in HIV-1C infection, the clade responsible for more than half of AIDS cases worldwide.

Keywords: HIV-1; RNAi; epigenetics; small interfering RNA; transcriptional gene silencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cells, Cultured
  • Gene Silencing / physiology
  • HIV Long Terminal Repeat / genetics*
  • HIV-1 / genetics*
  • HIV-1 / metabolism
  • Humans
  • Leukocytes, Mononuclear / physiology*
  • Leukocytes, Mononuclear / virology*
  • Proviruses / genetics*
  • Proviruses / metabolism
  • RNA, Double-Stranded / genetics*
  • Virus Activation / genetics
  • Virus Replication / genetics*

Substances

  • RNA, Double-Stranded